Pacific Biosciences shares rise 1.30% premarket after announcing significant advancement in genomic sequencing.

Pacific Biosciences Of California, Inc. rose 1.30% in premarket trading, with the company announcing a significant advancement in global genomic equity. Researchers published the first Arab human pangenome in Nature Communications, powered by PacBio’s HiFi long-read sequencing. The study, led by Mohammed Bin Rashid University of Medicine and Health Sciences, assembled high-resolution genomes from 53 individuals representing diverse Arab populations across eight countries. This study resulted in millions of newly identified variants and over 111 million base pairs of previously unsequenced DNA, in genomic regions that were missing from widely used human references.